Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Double-Blind, Randomized, Placebo-Controlled Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus

NCT03218501 is registered in ClinicalTrials.gov with Sanwa Kagaku Kenkyusho Co., Ltd. as lead sponsor.

NCT NCT03218501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03218501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Double-Blind, Randomized, Placebo-Controlled Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus
Lead sponsor
Sanwa Kagaku Kenkyusho Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
August 28, 2017
Completion date
May 25, 2018
Enrollment
269 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uremic pruritus in hemodialysis patients